Anzeige
Mehr »
Login
Freitag, 15.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Strategische Partnerschaft für sichere KI- und Quantentechnologie im Gesundheitswesen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
198 Leser
Artikel bewerten:
(1)

Hospital-Acquired Infection Control Market to Reach $25.00 Bn, Globally, by 2030 at 4.6% CAGR: Allied Market Research

Finanznachrichten News

Increase in incidence of hospital-acquired infections and rise in likelihood of epidemic or pandemic outbreaks drive the growth of the global hospital-acquired infection control market.

PORTLAND, Ore., Aug. 19, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Hospital-Acquired Infection Control Market by Product & Service (Sterilization, Cleaning & Disinfection Products, Protective Barriers, and Endoscope Reprocessing Products), Infection Type (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections (UTI), and Others), and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2022-2030." According to the report, the global hospital-acquired infection control industry generated $19.95 billion in 2020, and is expected to generate $25.00 billion by 2030, witnessing a CAGR of 4.6% from 2022 to 2030.

Allied Market Research Logo

For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/11359

Drivers, restraints, and opportunities

Increase in incidence of hospital-acquired infections, rise in likelihood of epidemic or pandemic outbreaks, and surge in chronic disease incidences drive the growth of the global hospital-acquired infection control market. However, fatal effects of chemical disinfectants hinder the market growth. On the other hand, high potential in emerging countries creates new opportunities in the coming years.

Covid-19 Scenario

  • Manufacturers of hospital-acquired infection (HAI) control products have been expanding their production capacities for medical nonwovens such as gloves, masks, and gowns to cater to the increase in demand with an outbreak of the Covid-19 pandemic.
  • Increase in the number of Covid-19 cases and rise in need for safety of healthcare workers are projected to increase the demand for protective barrier products and disposable hospital supplies. This would present new avenues for manufacturers of HAI control products.
  • With rise in number of surgeries performed at hospitals and need for safety and prevention of cross-contamination in clinics, the demand for sterilization and cleaning and disinfection products would also rise.

The protective barriers segment to maintain its lead position during the forecast period

Based on product & service, the protective barriers segment held the largest share in 2020, accounting for more than three-fourths of the global hospital-acquired infection control market, and is estimated to maintain its lead position during the forecast period. This is due to surge in adoption of medical nonwovens such as surgical drapes, face masks, and gowns with increase in Covid-19 cases, rise in number of surgeries, and surge in public awareness toward personal hygiene. However, the sterilization segment is projected to witness the largest CAGR of 5.9% from 2022 to 2030, owing to rise in hospital-acquired infections (HAI), surge in outsourcing of sterilization services, re-introduction of ethylene oxide sterilization, and increase in the incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/11359

The hospitals and clinics segment to continue its leadership status throughout the forecast period

Based on end user, the hospitals and clinics segment accounted for the highest share in 2020, contributing to more than three-fourths of the global hospital-acquired infection control market, and is projected to continue its leadership status throughout the forecast period. Moreover, this segment is expected to portray the fastest CAGR of 4.8% from 2022 to 2030. This is attributed to increase in the geriatric population that is more susceptible to various chronic diseases, surge in volume of surgical procedures carried out in hospitals, and increase in number of hospitals & clinics worldwide. The report also analyzes the segments including ambulatory surgical centers and others.

North America to continue its dominant share by 2030

Based on region, North America contributed to the largest market share in terms of revenue in 2020, holding more than one-third of the global hospital-acquired infection control market, and is expected to continue its dominant share by 2030. This is due to increase in adoption of sterilization & disinfection products along with contract sterilization services and surge in need for hospital-acquired infection control measures to minimize the prevalence. However, Asia-Pacific is estimated to manifest the fastest CAGR of 5.4% during the forecast period, owing to rise in awareness related to personal hygiene, surge in the number of surgical procedures, availability of trained medical professionals, and favorable reimbursement policies in the healthcare system.

Leading Market Players

  • 3M Company
  • Belimed AG
  • Ecolab Inc.
  • Fortive (Advanced Sterilization Products)
  • Getinge AB
  • Matachana Group
  • Miele Group
  • MMM Group
  • Sotera Health LLC
  • Steris Plc. (Cantel Medical Corporation)

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.

Similar Reports:

Telemedicine Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Fertility Test Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Spirometer Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Disposable Syringes Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Workplace Stress Management Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Monoclonal Antibodies Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Personal Mobility Devices Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

© 2021 PR Newswire
Treibt Nvidias KI-Boom den Uranpreis?
In einer Welt, in der künstliche Intelligenz zunehmend zum Treiber technologischer Fortschritte wird, rückt auch der Energiebedarf, der für den Betrieb und die Weiterentwicklung von KI-Systemen erforderlich ist, in den Fokus.

Nvidia, ein Vorreiter auf dem Gebiet der KI, steht im Zentrum dieser Entwicklung. Mit steigender Nachfrage nach leistungsfähigeren KI-Anwendungen steigt auch der Bedarf an Energie. Uran, als Schlüsselkomponente für die Energiegewinnung in Kernkraftwerken, könnte dadurch einen neuen Stellenwert erhalten.

Dieser kostenlose Report beleuchtet, wie der KI-Boom potenziell den Uranmarkt beeinflusst und stellt drei aussichtsreiche Unternehmen vor, die von diesen Entwicklungen profitieren könnten und echtes Rallyepotenzial besitzen

Handeln Sie Jetzt!

Fordern Sie jetzt den brandneuen Spezialreport an und profitieren Sie von der steigenden Nachfrage, der den Uranpreis auf neue Höchststände treiben könnte.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.